Production and evaluation of an antimicrobial peptide-containing wafer formulation for topical application

Current Microbiology

Volumn 66, Issue 3, 2013, Pages 271-278

  O'Driscoll, Noelle H ^a   Labovitiadi, Olga ^b   Cushnie, T P Tim ^c   Matthews, Kerr H ^a   Mercer, Derry K ^d   Lamb, Andrew J ^a  

^a ROBERT GORDON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GREENWICH   (United Kingdom)

^c MAHASARAKHAM UNIVERSITY   (Thailand)

^d NOVABIOTICS LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL PEPTIDE NP101; ANTIMICROBIAL PEPTIDE NP108; POLYMER; POLYPEPTIDE ANTIBIOTIC AGENT; POTASSIUM; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL WAFER; ARTICLE; CELL AGGREGATION; CELL STRUCTURE; DRUG DOSAGE FORM; DRUG FORMULATION; ESCHERICHIA COLI; FREEZE DRYING; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POTASSIUM DEPLETION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; TOPICAL DRUG ADMINISTRATION; WOUND INFECTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84878385956     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-012-0268-3     Document Type: Article

References (28)

1. Aucken H, Ganner M, Murchan S, Cookson B, Johnson A (2002) A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics. J Antimicrob Chemother 50:171-175. doi: 10.1093/jac/dkf117
2. Bhat S, Milner S (2007) Antimicrobial peptides in burns and wounds. Curr Protein Pept Sci 8:506-520
3. Boateng JS, Matthews KH, Auffret AD, Humphrey MJ, Stevens HN, Eccleston GM (2009) In vitro drug release studies of polymeric freeze-dried wafers and solvent-cast films using paracetamol as a model soluble drug. Int J Pharm 378:66-72. doi: 10.1016/j.ijpharm.2009.05.038
4. Boateng JS, Auffret AD, Matthews KH, Humphrey MJ, Stevens HNE, Eccleston GM (2010) Characterisation of freeze-dried wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces. Int J Pharm 389:24-31. doi: 10.1016/j.ijpharm.2010.01.008
5. Chua K, Laurent F, Coombs G, Grayson ML, Howden BP (2011) Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy. Clin Infect Dis 52:99-114. doi: 10.1093/cid/ciq067
6. Deming TJ (2007) Synthetic polypeptides for biomedical applications. Prog Polym Sci 32:858-875. doi: 10.1016/j.progpolymsci.2007.05.010
7. Fonder MA, Lazarus GS, Cowan DA, Aronson-Cook B, Kohli AR, Mamelak AJ (2008) Treating the chronic wound: a practical approach to the care of nonhealing wounds and wound care dressings. J Am Acad Dermatol 58:185-206
8. Hale JDF, Hancock REW (2007) Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti Infect Ther 10:951-959. doi: 10.1586/14787210.5.6.961
9. Hancock RE, Sahl HG (2006) Antimicrobial and host-defence peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24:1551-1557. doi: 10.1038/nbt1267
10. Lambert PA, Hammond SM (1973) Potassium fluxes, first indications of membrane damage in micro-organisms. Biochem Biophys Res Commun 54:796-799. doi: 10.1016/0006-291X(73)91494-0
11. Lu H, Tonge PJ (2010) Drug-target residence time: critical information for lead optimization. Curr Opin Chem Biol 14:467-474. doi: 10.1016/j.cbpa.2010. 06.176
12. Malmsten M, Kasetty G, Pasupuleti M, Alenfall J, Schmodtchen A (2011) Highly selective end-tagged antimicrobial peptides derived from PRELP. PLoS ONE 6:e16400. doi: 10.1371/journal.pone.0016400
13. Martin N, Dodds C (2006) Protective mechanisms of the body. Anaesth Intensive Care Med 7:459-461. doi: 10.1053/j.mpaic.2006.09.008
14. Matthews KH, Stevens HNE, Auffret AD, Humphrey MJ, Eccleston GM (2005) Lyophilised wafers as a drug delivery system for wound healing containing methylcellulose as a viscosity modifier. Int J Pharm 289:51-62. doi: 10.1016/j.ijpharm.2004.10.022
15. Matthews KH, Stevens HNE, Auffret AD, Humphrey MJ, Eccleston GM (2008) Formulation, stability and thermal analysis of lyophilised wound healing wafers containing an insoluble MMP-3 inhibitor and a non-ionic surfactant. Int J Pharm 356:110-120. doi: 10.1016/j.ijpharm.2007.12.043
16. O'Neil D, Mercer D, Charrier C (2006) Inhibition of biofilm organisms. International Patent A61K 38/04
17. Pag U, Oedenkoven M, Sass V, Shai Y, Shamova O, Antcheva N, Tossi A, Sahl HG (2008) Analysis of in vitro activities and models of action of synthetic antimicrobial peptides derived from an alpha-helical 'sequence template'. J Antimicrob Chemother 61:341-352. doi: 10.1093/jac/dkm479
18. Pereira HA (2006) Novel therapies based on cationic antimicrobial peptides. Curr Pharm Biotechnol 7:229-234. doi: 10.2174/138920106777950771
19. Reddy KVR, Yedery RD, Aranha C (2004) Antimicrobial peptides: premises and promises. Int J Antimicrob Agents 24:536-547. doi: 10.1016/j.ijantimicag. 2004.09.005
20. Schauber J, Gallo RL (2008) Antimicrobial peptides and the skin immune defence system. J Allergy Clin Immunol 122:261-266. doi: 10.1016/j.jaci.2008.03. 027
21. Shukla A, Fleming KE, Chuang HF, Chau TM, Loose CR, Stephanopoulos GN, Hammond PT (2010) Controlling the release of peptide antimicrobial agents from surfaces. Biomaterials 31:2348-2357. doi: 10.1016/j.biomaterials.2009.11.082
22. Steinberg DA, Hurst MA, Fujii CA, Kung AH, Ho JF, Cheng FC, Loury DJ, Fiddes JC (1997) Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother 41:1738-1742
23. Stephens PJ (2011) Dysfunctional wound healing in chronic wounds. In: Farrar D (ed) Advanced wound repair therapies. Woodhead Publishing Limited, Cambridge, pp 3-23
24. Superti F, Ammendolia M, Marchetti M (2008) New advances in anti-HSV chemotherapy. Curr Med Chem 15:900-911. doi: 10.2174/092986708783955419
25. Supp DM, Neely AN (2008) Cutaneous antimicrobial gene therapy: engineering human skin replacements to combat wound infection. Expert Rev Dermatol 3:73-84. doi: 10.1586/17469872.3.1.73
26. Tenover FC, Goering RV (2009) Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother 64:441-446. doi: 10.1093/jac/dkp241
27. Wild T, Rahbarnia A, Kellner M, Sobotka L, Eberlein T (2010) Basics in nutrition and wound healing. Nutrition 26:862-866. doi: 10.1016/j.nut.2010.05. 008
28. Zaiou M (2007) Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J Mol Med 85:317-329. doi: 10.1007/s00109-006-0143-4